Table 2.
Controls (n=1728) N |
BE (n=310) N |
Crude OR (95% CI) |
Adjusted ORa (95% CI) |
||
---|---|---|---|---|---|
Non-coffee drinker | 510 | 71 | Referent | Referent | |
Ever coffee drinkers | 1218 | 239 | 1.41 (1.06-1.87) | 1.04 (0.76-1.42) | |
Caffeinated (drinks/day) |
|||||
0-<1 | 88 | 14 | 1.14 (0.62-2.12) | 1.19 (0.62-2.28) | |
1-<2 | 280 | 33 | 0.85 (0.55-1.31) | 0.73 (0.46-1.17) | |
2-<3 | 327 | 66 | 1.45 (1.01-2.08) | 1.07 (0.72-1.59) | |
3-<4 | 219 | 54 | 1.77 (1.20-2.61) | 1.11 (0.72-1.70) | |
≥4 | 130 | 38 | 2.10 (1.35-3.26) | 1.22 (0.76-1.98) | |
P-trend in coffee drinkers | 0.002 | 0.30 | |||
Decaffeinated (drinks/day) |
|||||
0-<1 | 27 | 3 | 0.80 (0.24-2.70) | 0.74 (0.21-2.65) | |
≥1 | 85 | 16 | 1.35 (0.75-2.44) | 1.20 (0.63-2.30) | |
Coffee strength | |||||
Weak | 53 | 8 | 1.08 (0.50-2.37) | 0.77 (0.34-1.75) | |
Medium | 771 | 146 | 1.36 (1.00-1.85) | 1.01 (0.72-1.41) | |
Strong | 324 | 76 | 1.69 (1.19-2.40) | 1.18 (0.80-1.73) | |
Coffee temperature | |||||
Cold | 6 | 2 | 2.39 (0.47-12.1) | 1.63 (0.30-9.01) | |
Warm | 156 | 26 | 1.20 (0.74-1.94) | 0.90 (0.54-1.50) | |
Hot or extremely hot | 1028 | 210 | 1.47 (1.10-1.96) | 1.08 (0.79-1.49) | |
Non-tea drinker | 850 | 130 | Referent | Referent | |
Ever tea drinkers | 878 | 180 | 1.34 (1.05-1.71) | 1.11 (0.85-1.44) | |
Caffeinated tea (drinks/day) |
|||||
0-<1 | 356 | 80 | 1.47 (1.08-1.99) | 1.25 (0.90-1.73) | |
1-<2 | 189 | 44 | 1.52 (1.05-2.22) | 1.18 (0.79-1.76) | |
≥2 | 149 | 28 | 1.23 (0.79-1.92) | 0.88 (0.55-1.40) | |
P-trend in tea drinkers | 0.45 | 0.14 | |||
Decaffeinated tea | |||||
Ever | 30 | 5 | 1.09 (0.42-2.86) | 0.66 (0.23-1.87) | |
Green tea | |||||
Ever | 85 | 13 | 1.00 (0.54-1.84) | 1.10 (0.57-2.11) | |
Tea temperature | |||||
Cold | 724 | 160 | 1.45 (1.12-1.86) | 1.13 (0.86-1.48) | |
Warm | 24 | 1 | 0.27 (0.04-2.03) | 0.45 (0.06-3.53) | |
Hot or extremely hot | 116 | 18 | 1.02 (0.60-1.72) | 1.09 (0.62-1.91) |
Adjusted for age, sex, race, WHR, GERD symptoms, smoking, alcohol use, H pylori infection, use of aspirin/NSAIDs, PPIs/H2RAs, and recruitment source.